Table 1.
Twenty SR reports’ total article numbers and rate of inclusion
| Total | Abstract N (%) | Full-text N (%) | |
|---|---|---|---|
|
| |||
| ACE Inhibitors16 | 2544 | 183 (7.19%) | 41 (1.61%) |
| ADHD16 | 851 | 84 (9.87%) | 20 (2.35%) |
| Antihistamines16 | 310 | 92 (29.68%) | 16 (5.16%) |
| Atypical Antipsychotics16 | 1120 | 363 (32.41%) | 146 (13.04%) |
| Beta Blockers16 | 2072 | 302 (14.58%) | 42 (2.03%) |
| Calcium Channel Blockers16 | 1218 | 279 (22.91%) | 100 (8.21%) |
| Estrogens16 | 368 | 80 (21.74%) | 80 (21.74%) |
| NSAIDS16 | 393 | 88 (22.39%) | 41 (10.43%) |
| Opioids16 | 1915 | 48 (2.51%) | 15 (0.78%) |
| Oral Hypoglycemics16 | 503 | 139 (27.63%) | 136 (27.04%) |
| Proton Pump Inhibitors16 | 1333 | 238 (17.85%) | 51 (3.83%) |
| Skeletal Muscle Relaxants16 | 1643 | 34 (2.07%) | 9 (0.55%) |
| Statins16 | 3465 | 173 (4.99%) | 85 (2.45%) |
| Triptans16 | 671 | 218 (32.49%) | 24 (3.58%) |
| Urinary Incontinence16 | 327 | 78 (23.85%) | 40 (12.23%) |
| Antibiotic17 | 412 | 74 (17.96%) | 10 (2.43%) |
| Antineoplastic18 | 1294 | N/A N/A | 19 (1.47%) |
| Antiretrovirals19 | 749 | N/A N/A | 38 (5.07%) |
| Hearing Loss20 | 467 | 13 (2.78%) | 3 (0.64%) |
| Leukaemia21 | 328 | 11 (3.35%) | 7 (2.13%) |